Dr. Carey Anders on Treating Brain Metastases in Breast Cancer

Publication
Video
Special ReportsBreast Cancer (Issue 2)
Volume 1
Issue 2

Carey Anders, MD, assistant professor for the Department of Medicine, Division of Hematology and Oncology, UNC Chapel Hill, on the challenge of treating brain metastases in breast cancer. Anders says brain metastases generally portend a poor prognosis and treatment for them are currently scarce.

Carey Anders, MD, assistant professor for the Department of Medicine, Division of Hematology and Oncology, UNC Chapel Hill, on the challenge of treating brain metastases in breast cancer. Anders says brain metastases generally portend a poor prognosis and treatment for them are currently scarce.

Articles in this issue
Glembatumumab and the Phase IIb Registrational METRIC Trial: Q&A With Denise Yardley, MD, and Linda Vahdat, MD
Glembatumumab and the Phase IIb Registrational METRIC Trial: Q&A With Denise Yardley, MD, and Linda Vahdat, MD
Survival Improved Over 10 Years With Breast-Conserving Therapy Versus Mastectomy
Survival Improved Over 10 Years With Breast-Conserving Therapy Versus Mastectomy
Dr. Carey Anders on Treating Brain Metastases in Breast Cancer
Dr. Carey Anders on Treating Brain Metastases in Breast Cancer
Dr. William Sikov on Triple-Negative Breast Cancer Patients Not Responding to Treatment
Dr. William Sikov on Triple-Negative Breast Cancer Patients Not Responding to Treatment
Dr. Matthew J. Ellis on Neoadjuvant Palbociclib in Primary Breast Cancer
Dr. Matthew J. Ellis on Neoadjuvant Palbociclib in Primary Breast Cancer
Avelumab Shows Efficacy in PD-L1-Positive Metastatic Breast Cancer
Avelumab Shows Efficacy in PD-L1-Positive Metastatic Breast Cancer
The Complications and Costs in Mastectomies and Lumpectomies in Early Breast Cancer
The Complications and Costs in Mastectomies and Lumpectomies in Early Breast Cancer
Study Links pCR Post-Neoadjuvant Therapy to Increased Survival Rates in TNBC
Study Links pCR Post-Neoadjuvant Therapy to Increased Survival Rates in TNBC
Recent Videos
Related Content
Can ChatGPT Prove Its Effectiveness in Health Care?

Can ChatGPT Prove Its Effectiveness in Health Care?

Grace Koennecke
January 19th 2025
Article

A study by UVA Health found that while ChatGPT Plus holds potential for enhancing diagnoses, physicians need better training to use AI effectively.

Read More

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Jordyn Sava;Sanjay K. Juneja, MD
January 15th 2025
Podcast

In this episode of Targeted Talks, Sanjay K. Juneja, MD, discusses the exciting advancements of artificial intelligence in 2024.

Listen

Emerging BsAbs and Their Impact in Multiple Myeloma

Emerging BsAbs and Their Impact in Multiple Myeloma

Morgan Bayer
January 17th 2025
Article

Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring early-line and maintenance use.

Read More

Unpacking the New Recommendations for Early-Stage Breast Cancer Management

Unpacking the New Recommendations for Early-Stage Breast Cancer Management

April 15th 2022
Podcast

In season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guideline for managing early-stage breast cancer.

Listen

What Is Dark Zone Lymphoma, and Is It Clinically Relevant?

What Is Dark Zone Lymphoma, and Is It Clinically Relevant?

Brett Collinge, PhD candidate;David W. Scott, MBChB, PhD
January 16th 2025
Article

Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated treatment, others remain resistant, highlighting the need for targeted approaches to improve outcomes.

Read More

Yared Considers Referral and Bridging Decisions for Early Relapse in DLBCL

Yared Considers Referral and Bridging Decisions for Early Relapse in DLBCL

Targeted Oncology Staff
January 16th 2025
Article

During a Case-Based Roundtable® event, Jean A. Yared, MD, moderated a discussion on the approach to CAR T-cell therapy for a patient with early relapsed diffuse large B-cell lymphoma.

Read More